Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q93009 (UBP7_HUMAN) Homo sapiens (Human)

Ubiquitin carboxyl-terminal hydrolase 7 UniProtKBInterProSTRINGInteractive Modelling

1102 aa; Sequence (Fasta) ; (Isoform 3)

Available Structures

63 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
USP7CD-UBL45 in complex with Ubiquitin Heteromer
P0CG47;
209-1102
Assess
USP7CD-CTP in complex with Ubiquitin Heteromer
P0CG47;
209-1102
CA;
Assess
Crystal structure of USP7/HAUSP in complex with ICP0 Heteromer
P08393;
560-1083
Assess
Crystal structure of DNMT1 in complex with USP7 Heteromer
P26358;
560-1083
Assess
Crystal Structure of human DNMT1 and USP7/HAUSP complex Heteromer
P26358;
560-1083
ZN;
Assess
Crystal structure of USP7 in complex with DNMT1(K1115Q) Heteromer
P26358;
560-1083
GOL;
Assess
Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquiti… Heteromer
P0CG48;
208-554
Assess
Crystal structure of USP7 ubiquitin-like domains in compact conformation Heteromer
P08393;
540-885
CL;
Assess
Crystal structure of USP7 catalytic domain [H294E] mutant in complex with ubiquitin Heteromer
P0CG47;
209-553
EPE;
Assess
Crystal structure of USP7 catalytic domain [L299A] mutant in complex with ubiquitin Heteromer
P0CG47;
208-551
GOL;
Assess
Crystal structure of USP7 catalytic domain [V302K] mutant in complex with ubiquitin Heteromer
P0CG47;
210-550
Assess
Crystal Structure of Ubl123 with an EZH2 peptide Heteromer
Q15910;
543-883
Assess
Crystal structure of USP7 ubiquitin-like domains in extended conformation Heteromer
P08393;
543-883
CL;
Assess
Crystal structure of USP7 catalytic domain [V302K] mutant in complex with ubiquitin (malonate bound) Heteromer
P0CG47;
210-549
MLA;GOL;
Assess
Crystal structure of USP7 with RNF169 peptide Heteromer
Q8NCN4;
562-885
Assess
Crystal structure of USP7 in complex with UHRF1 Heteromer
Q96T88;
561-881
Assess
Structure of USP7 with a novel viral protein Heteromer
F5HF68;
63-205
GOL;
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 364-367 Heteromer
P04637;
63-205
Assess
Structure of the vIRF4-HAUSP TRAF domain complex Heteromer
Q2HR73;
63-205
Assess
Crystal Structure Of USP7-NTD with MCM-BP Heteromer
Q9BTE3;
63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with an EBNA1 peptide Heteromer
P03211;
63-205
21×NA;
Assess
Crystal Structure of the USP7:HdmX(AHSS) complex Heteromer
O15151;
63-205
Assess
Crystal structure of usp7-ntd with an e2 enzyme Heteromer
P51965;
63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with mdm2 peptide 147-150 Heteromer
Q00987;
63-205
Assess
The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 359-362 Heteromer
P04637;
63-205
Assess
Crystal Structure of the USP7:Hdm2(PSTS) complex Heteromer
Q00987;
63-205
Assess
Crystal structure of USP7 in complex with a 4-hydroxypiperidine based inhibitorhomo-2-mer207-560
SO4;GOL;CQ5;
Assess
Structure of DUB complexhomo-2-mer208-554
9QA;
Assess
High-resolution X-ray cocrystal structure of USP7 in complex with X4homo-2-mer207-553
DYO;
Assess
Structure of DUB complexhomo-2-mer208-554
9QD;ACT;GOL;
Assess
USP7 in complex with a novel inhibitorhomo-2-mer209-553
EZF;
Assess
structure of usp7 catalytic domain and three ubl-domainsmonomer210-881
Assess
Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activationmonomer211-881
Assess
Crystal structure of USP7 in complex with its inhibitormonomer560-1084
EIB;
Assess
Crystal structure of USP7-HUBL domainmonomer560-1083
Assess
Mechanism of USP7 (HAUSP) activation by its C-terminal ubiquitin-like domain (HUBL) and allosteric …monomer560-1083
CL;
Assess
Crystal structure of HAUSPmonomer64-551
Assess
Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibit…monomer207-560
SO4;GOL;8QQ;
Assess
Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibit…monomer207-560
SO4;GOL;8RN;
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 1monomer207-555
R4D;
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 14monomer207-555
R4J;ZN;
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 18monomer207-554
R44;ACT;
Assess
Crystal structure of the USP7/HAUSP catalytic domainmonomer208-554
BR;
Assess
The Crystal Structure of human USP7 USP domain from Biortusmonomer208-554
GOL;
Assess
Structure of the catalytic domain of USP7 (HAUSP)monomer208-554
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 7monomer207-553
R41;
Assess
Crystal structure of the USP7/HAUSP catalytic domainmonomer209-554
BR;
Assess
USP7 in complex with GNE6776 (6'-amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-c…monomer209-554
8JP;
Assess
Crystal structure of USP7 in complex with the covalent inhibitor, FT827monomer209-554
8WN;EDO;
Assess
USP7 in complex with Cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl)phenol)monomer209-554
AJJ;GOL;
Assess
Crystal structure of USP7 in complex with the non-covalent inhibitor, FT671monomer212-556
8WK;
Assess
USP7 IN COMPLEX WITH LIGAND COMPOUND 23monomer208-552
R3Y;
Assess
Structure of DUB complexmonomer208-552
9HS;ZN;
Assess
Crystal structure of USP7 in complex with allosteric inhibitor FX1-3763monomer209-552
QBL;
Assess
USP7 in complex with GNE6640 (4-(2-amino-4-ethyl-5-(1H-indazol-5-yl)pyridin-3-yl)phenol)monomer210-553
8JM;
Assess
Crystal structure of the apo-form of USP7 catalytic domain [V302K] mutantmonomer211-553
GOL;
Assess
High-resolution X-ray cocrystal structure of USP7 in complex with LX04-46monomer211-553
DVU;
Assess
Crystal structure of the first two Ubl domains of Deubiquitylase USP7monomer537-793
Assess
Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a p53 peptidemonomer63-208
Assess
Crystal structure of the TRAF-like domain of HAUSP/USP7monomer63-206
CA;
Assess
Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a MDM2 peptidemonomer63-205
Assess
Crystal structure of the N-terminal domain of USP7/HAUSP.monomer65-203
Assess
Solution NMR structure of human ubiquitin specific protease Usp7 UBL domain (residues 537-664). NES…monomer537-664
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5fwi.1.Amonomer0.83210-881
100.00
Assess
4yoc.1.Bmonomer0.82560-1083
100.00
Assess
2f1x.1.Amonomer0.7463-208
96.18
Assess
5jtv.4.Amonomer0.57209-1102
98.79
Assess

5 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 35fwi.1.Amonomer0.82194-865
100.00
Assess
Isoform 34yoc.1.Bmonomer0.82544-1067
100.00
Assess
Isoform 32f1x.1.Amonomer0.7447-192
96.18
Assess
Isoform 35jtv.4.Amonomer0.57193-1086
98.79
Assess
Isoform 37yui.1.Amonomer0.50669-1017
12.36
Assess